TP
TNF Pharmaceuticals, Inc.
SEC filingPharmaceuticals · New York, NY
Amount raised$7Msold at filing
Total offering$7M
Investors in the raise12count reported to the SEC
FiledSep 5, 2025first sale Sep 2, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Christopher SchreiberDirector
Bruce BernsteinDirector
Ian RhodesExecutive Officer
Mitchell J. GlassExecutive Officer, Director
Stephen J. FrisciaDirector
Bill J. WhiteDirector
Joshua SilvermanExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.